Suppr超能文献

发表的改善抗高血压和降脂药物依从性的干预措施的建模终生成本效益。

The modeled lifetime cost-effectiveness of published adherence-improving interventions for antihypertensive and lipid-lowering medications.

机构信息

US Health Economics and Outcomes Research, IMS Health, Falls Church, VA 22046, USA.

出版信息

Value Health. 2010 Sep-Oct;13(6):685-94. doi: 10.1111/j.1524-4733.2010.00774.x.

Abstract

OBJECTIVE

We sought to compare the cost-effectiveness of different interventions that have been shown to improve adherence with antihypertensive and lipid-lowering therapy, by combining a burden of nonadherence model framework with literature-based data on adherence-improving interventions.

METHODS

MEDLINE was reviewed for studies that evaluated ≥1 adherence intervention compared with a control, used an adherence measure other than self-report, and followed patients for ≥6 months. Effectiveness was assessed as Relative Improvement, ratio of adherence with an intervention versus control. Costs, standardized to 12 months and adjusted to 2007 US$, and effectiveness estimates for each intervention were entered into a previously published model designed to measure the burden of nonadherence with antihypertensive and lipid-lowering medications, in a hypertensive population. Outputs included direct medical costs and incremental costs per quality-adjusted life-year (QALY) gained.

RESULTS

After screening, 23 eligible adherence-improving interventions were identified from 18 studies. Relative Improvement ranged from 1.13 to 3.60. After eliminating more costly/less effective interventions, two remained. Self-monitoring, reminders, and educational materials incurred total health-care costs of $17,520, and compared with no adherence intervention, had an incremental cost-effectiveness ratio (ICER) of $4984 per QALY gained. Pharmacist/nurse management incurred total health-care costs of $17,896, and versus self-monitoring, reminders, and education had an ICER of $6358 per QALY gained.

CONCLUSIONS

Of published interventions shown to improve adherence, reminders and educational materials, and a pharmacist/nurse management program, appear to be cost-effective and should be considered before other interventions. Understanding relative cost-effectiveness of adherence interventions may guide design and implementation of efficient adherence-improving programs.

摘要

目的

通过结合不依从负担模型框架和基于文献的依从性改善干预措施数据,比较已证明可提高抗高血压和降脂治疗依从性的不同干预措施的成本效益。

方法

对评估了≥1种依从性干预措施与对照的研究进行了 MEDLINE 综述,这些研究使用了除自我报告以外的依从性测量方法,并随访患者≥6 个月。有效性评估为相对改善,即干预措施与对照的依从性比值。将每种干预措施的成本(标准化为 12 个月并调整为 2007 年的美元)和有效性估计值输入到先前发表的模型中,该模型旨在衡量高血压人群中不依从抗高血压和降脂药物的负担。结果包括直接医疗成本和每获得 1 个质量调整生命年(QALY)的增量成本。

结果

经过筛选,从 18 项研究中确定了 23 项符合条件的依从性改善干预措施。相对改善范围从 1.13 到 3.60。在消除了成本更高/效果更差的干预措施后,仍有两种保留下来。自我监测、提醒和教育材料的总医疗保健成本为 17520 美元,与无依从性干预相比,每获得 1 个 QALY 的增量成本效益比(ICER)为 4984 美元。药剂师/护士管理的总医疗保健成本为 17896 美元,与自我监测、提醒和教育相比,每获得 1 个 QALY 的 ICER 为 6358 美元。

结论

在所发表的改善依从性的干预措施中,提醒和教育材料以及药剂师/护士管理计划似乎具有成本效益,应在其他干预措施之前考虑。了解依从性干预措施的相对成本效益可能有助于指导高效依从性改善计划的设计和实施。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验